Hutchin Hill Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Hutchin Hill Capital’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$844K	Buy	+13,100	New	+$815K	0.24%	95
2017 Q2	–	Sell	-26,500	Closed	-$1.31M	–	824
2017 Q1	$1.31M	Buy	+26,500	New	+$1.49M	0.04%	421
2015 Q2	–	Sell	-49,500	Closed	-$3.1M	–	644
2015 Q1	$3.1M	Buy	+49,500	New	+$3.01M	0.09%	245
2014 Q2	–	Sell	-9,700	Closed	-$304K	–	601
2014 Q1	$304K	Buy	+9,700	New	+$257K	0.02%	527

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Hutchin Hill Capital's ANIP Position: Q4 2017 in Review

Hutchin Hill Capital opened a new position in ANI Pharmaceuticals (ANIP) in Q4 2017: 13,100 shares worth $844K. The stake represents 0.24% of the portfolio and ranks #95 among its holdings. This is a return to the name: Hutchin Hill Capital previously reported a position in ANIP as recently as Q1 2017.

Hutchin Hill Capital first reported a position in ANIP in Q1 2014 and has held it in 4 quarters since. The position peaked at $3.1M in Q1 2015. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

Hutchin Hill Capital held 13,100 shares of ANI Pharmaceuticals worth $844K as of Q4 2017.
ANI Pharmaceuticals was a new Hutchin Hill Capital position in Q4 2017.
ANI Pharmaceuticals made up 0.24% of Hutchin Hill Capital's portfolio in Q4 2017, its #95 holding.
Hutchin Hill Capital first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 4 quarters since.
Hutchin Hill Capital's ANI Pharmaceuticals position peaked at $3.1M in Q1 2015.
163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.